Recode Therapeutics, Inc.

Biotechnology company · Menlo Park, California, United States

Recode Therapeutics, Inc. is a biotechnology company headquartered in Menlo Park, California, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $29 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Recode Therapeutics at a glance

Typebiotechnology company
HeadquartersMenlo Park, California, United States
Earliest incorporation on record2020
SEC CIK1693764

What does Recode Therapeutics do?

Private fundraising reported to the SEC

9 Form D notices; the most recent reported $29.4 million sold (2025).

Frequently asked questions about Recode Therapeutics

Where is Recode Therapeutics headquartered?

Recode Therapeutics, Inc. is headquartered in Menlo Park, California, United States.

What does Recode Therapeutics do?

Recode Therapeutics, Inc. is a biotechnology company.

When was Recode Therapeutics founded?

The earliest incorporation on record for Recode Therapeutics, Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences